Actavis Pharma Inc

General

Total Cases85
Active Cases--
Patents--
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
L3
E
PTAB
L1
D
CAFC
L3
C

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
02/07/24
Letter to Randall C. Lohan, Clerk and Nicole Fasano, Case Manager from David A. Bilson regarding Defendant's trial exhibits in this matter may be destroyed. (Bilson, David) (Entered: 02/07/2024)
02/07/24
Letter to Randall C. Lohan, Clerk and Nicole Fasano, Case Manager from David A. Bilson regarding Defendant's trial exhibits in this matter may be destroyed. (Bilson, David) (Entered: 02/07/2024)
02/07/24
Letter to Randall C. Lohan, Clerk and Nicole Fasano, Case Manager from David A. Bilson regarding Defendant's trial exhibits in this matter may be destroyed. (Bilson, David) (Entered: 02/07/2024)
02/07/24
Remark: Defendant Actavis Laboratories FL, Inc.'s trial exhibits have been destroyed per D.I. 216 . (nmf) (Entered: 02/07/2024)
02/07/24
Remark: Defendant Actavis Laboratories FL, Inc.'s trial exhibits have been destroyed per D.I. 216 . (nmf) (Entered: 02/07/2024)
02/07/24
Remark: Defendant Actavis Laboratories FL, Inc.'s trial exhibits have been destroyed per D.I. 216 . (nmf) (Entered: 02/07/2024)
02/06/24
ACKNOWLEDGMENT OF RECEIPT of Plaintiff's Trial Exhibits (nmf) (Entered: 02/06/2024)
02/06/24
ACKNOWLEDGMENT OF RECEIPT of Plaintiff's Trial Exhibits (nmf) (Entered: 02/06/2024)
02/06/24
ACKNOWLEDGMENT OF RECEIPT of Plaintiff's Trial Exhibits (nmf) (Entered: 02/06/2024)
04/11/23
ACKNOWLEDGMENT OF RECEIPT of Plaintiff's Trial Exhibits. Filed by Amgen Inc.. (vfm) (Entered: 04/11/2023)